TauRx's Hydromethylthionine Mesylate (HMTM) Demonstrates Sig

TauRx's Hydromethylthionine Mesylate (HMTM) Demonstrates Significant Reduction in Neurodegeneration in Alzheimer's Disease (AD) | National Business

ABERDEEN, Scotland--(BUSINESS WIRE)--Jul 16, 2023--

Related Keywords

Singapore , United States , United Kingdom , Danielle Thomson , Rebecca Andersen , Henrik Zetterberg , Claude Wischik , Taurx Pharmaceuticals Ltd , Queen Square Institute Of Neurology , Square Institute , Executive Chairman , Taurx Pharmaceuticals , Business Wire , National Business ,